Asahi Kasei

Investor type Venture Capital
Founders Shitagau Noguchi

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 21
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 19
Rounds per year 0.23
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 2
Key employees 1

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Manufacturing
  • Pharmaceutical
Summary

Asahi Kasei appeared to be the Corporate Investor, which was created in 1931. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Clinical Trials. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Atox Bio, Artisan Pharma, Arcterus.

The high activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 25 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Asahi Kasei works on 20 percentage points less the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Asahi Kasei, startups are often financed by New Leaf Venture Partners, Tribeca Venture Partners, Pritzker Group Venture Capital. The meaningful sponsors for the fund in investment in the same round are Z-kai, Yuval Tal, Tribeca Venture Partners. In the next rounds fund is usually obtained by General Motors Ventures, Z-kai, Vincent Deltrieu.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Asahi Kasei:
Typical Co-investors
Asahi Kasei is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Asahi Kasei:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CIC Capital France, Ile-de-France, Paris
Mill Rock Capital New York, New York, United States
Pareto Securities -
Ronglian Chuangfu Beijing, China, Haidian
RZN8 Capital Kentucky, Louisville, United States
The Unofficial Syndicate -
TNG Fintech Group Inc. China, Hong Kong, Hong Kong Island
Tokyo Gas Chiyoda, Japan
Trolley Venture Partners Richmond, United States, Virginia
XL Axiata Tbk Indonesia, Jakarta, Jakarta Raya

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HistoWiz

Artificial Intelligence
Biotechnology
Database
Government
Health Care
Hospital
Life Science
Medical
Pharmaceutical
Veterinary
$32M19 Oct 2021 New York, New York, United States

Plant Prefab

Architecture
Construction
GreenTech
Manufacturing
Smart Building
$30M03 Aug 2021 California, United States

Glycomine

Biotechnology
Pharmaceutical
Therapeutics
$35M23 Jun 2021 San Francisco, California, United States

Super

Home Services
InsurTech
Subscription Service
$50M19 May 2021 San Francisco, California, United States

SetPoint Medical

Biotechnology
Health Care
Medical Device
Neuroscience
$64M27 Jan 2021 Santa Clarita, California, United States

Business Information Systems
Document Management
Information Services
Manufacturing
$16M01 Dec 2020 Osaka Prefecture

Aryballe Technologies

Electronics
Manufacturing
Nanotechnology
$8M10 Jul 2020 Grenoble, Auvergne-Rhône-Alpes, France

UltraSense Systems

Consumer Electronics
Information Technology
Sensor
Software
$20M18 Feb 2020 San Jose, California, United States

AiCure

Analytics
Artificial Intelligence
Clinical Trials
Health Care
Machine Learning
Medical
Software
$24M07 Nov 2019 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Asahi Kasei?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: